These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7128701

  • 1. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
    Hirschhorn ID, Makman MH.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):61-7. PubMed ID: 7128701
    [Abstract] [Full Text] [Related]

  • 2. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ, Wreggett KA, Seeman P.
    J Neurosci; 1982 Jul 10; 2(7):895-906. PubMed ID: 6124583
    [Abstract] [Full Text] [Related]

  • 3. Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat.
    Hirschhorn ID, Makman MH, Sharpless NS.
    Brain Res; 1982 Feb 25; 234(2):357-68. PubMed ID: 7199364
    [Abstract] [Full Text] [Related]

  • 4. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
    Bradbury AJ, Costall B, Naylor RJ.
    J Pharm Pharmacol; 1983 Nov 25; 35(11):738-45. PubMed ID: 6139456
    [Abstract] [Full Text] [Related]

  • 5. Binding of [3H]ADTN to rat striatal membranes.
    Templeton WW, Woodruff GN.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1629-32. PubMed ID: 6124259
    [Abstract] [Full Text] [Related]

  • 6. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965
    [Abstract] [Full Text] [Related]

  • 7. Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
    Hirschhorn ID, Makman MH, Gardner EL.
    Eur J Pharmacol; 1980 Mar 07; 62(1):123-4. PubMed ID: 6154585
    [No Abstract] [Full Text] [Related]

  • 8. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
    Mulder TB, Grol CJ, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1985 May 28; 112(1):73-9. PubMed ID: 4018139
    [Abstract] [Full Text] [Related]

  • 9. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P, Woodruff GN, Poat JA.
    Eur J Pharmacol; 1979 Apr 15; 55(2):137-42. PubMed ID: 456412
    [Abstract] [Full Text] [Related]

  • 10. Changes in (3H)-ADTN binding to microsomal and synaptic membrane fractions from rat striata following kainic acid lesions.
    Davis A, Woodruff GN, Poat JA, Freedman SB.
    Biochem Pharmacol; 1980 Jun 15; 29(12):1645-8. PubMed ID: 7406893
    [No Abstract] [Full Text] [Related]

  • 11. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y, Abel M.
    Res Commun Chem Pathol Pharmacol; 1978 Oct 15; 22(1):15-25. PubMed ID: 725314
    [Abstract] [Full Text] [Related]

  • 12. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
    Westerink BH, Dijkstra D, Feenstra MG, Horn AS, Rollema H.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):115-21. PubMed ID: 7398758
    [Abstract] [Full Text] [Related]

  • 13. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
    Sanvarinda Y, Phivthongngam L, Govitrapong P.
    Neurochem Int; 1998 Aug 13; 33(2):187-93. PubMed ID: 9761463
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW, Baldessarini RJ, Lamont JS, Amlicke D, Neumeyer JL.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2873-80. PubMed ID: 6626260
    [Abstract] [Full Text] [Related]

  • 15. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA.
    Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944
    [Abstract] [Full Text] [Related]

  • 16. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ, Breese GR, Morell P.
    Brain Res; 1980 Sep 15; 197(1):95-112. PubMed ID: 6156743
    [Abstract] [Full Text] [Related]

  • 17. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
    Osborne NN.
    Cell Mol Neurobiol; 1981 Jun 15; 1(2):167-74. PubMed ID: 7346167
    [Abstract] [Full Text] [Related]

  • 18. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
    Rollema H, Feenstra MG, Grol CJ, Lewis MH, Staples L, Mailman RB.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr 15; 332(4):338-45. PubMed ID: 3736679
    [Abstract] [Full Text] [Related]

  • 19. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD, Jenner P, Kelly E, Marsden CD.
    Br J Pharmacol; 1983 Jun 15; 79(2):599-610. PubMed ID: 6418246
    [Abstract] [Full Text] [Related]

  • 20. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ, Horowitz SG, Dvorkin B, Makman MH.
    Brain Res; 1980 Jun 16; 192(1):185-94. PubMed ID: 7378779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.